SCHEMBL2916488

SCHEMBL2916488

NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CC[C@@H](N)C(=O)O

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.62
▸ KMT2A Q03164 2/20 0.62
▸ KDM4E B2RXH2 1/20 0.62
▸ LMNA P02545 1/20 0.62
▸ MPO P05164 1/20 0.62
▸ MAPT P10636 1/20 0.62
▸ TSHR P16473 1/20 0.62
▸ BLM P54132 1/20 0.62
▸ PMP22 Q01453 1/20 0.62
▸ HIF1A Q16665 1/20 0.62
▸ ECE1 P42892 4/20 0.56
▸ HPGDS O60760 2/20 0.55
▸ HCRTR1 O43613 1/20 0.54
▸ ERAP2 Q6P179 1/20 0.54
▸ ALOX15 P16050 1/20 0.54
▸ ACE P12821 3/20 0.53
▸ ITGB2 P05107 1/20 0.53
▸ ICAM1 P05362 1/20 0.53
▸ ITGAL P20701 1/20 0.53
▸ PPARG P37231 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Golotimod SCHEMBL12966340 0.93 KDM4E (0.65) MEN1KMT2AKDM4ELMNAMPO
Golotimod SCHEMBL14790029 0.93 KDM4E (0.65) MEN1KMT2AKDM4ELMNAMPO
Orilotimod SCHEMBL29379690 0.93 KDM4E (0.65) MEN1KMT2AKDM4ELMNAMPO
Golotimod SCHEMBL726938 0.93 KDM4E (0.65) MEN1KMT2AKDM4ELMNAMPO
Golotimod SCHEMBL726291 0.93 KDM4E (0.65) MEN1KMT2AKDM4ELMNAMPO
Golotimod SCHEMBL12818886 0.93 KDM4E (0.65) MEN1KMT2AKDM4ELMNAMPO
Golotimod SCHEMBL29622906 0.93 KDM4E (0.65) MEN1KMT2AKDM4ELMNAMPO
Orilotimod SCHEMBL733964 0.93 KDM4E (0.65) MEN1KMT2AKDM4ELMNAMPO
Golotimod SCHEMBL1768729 0.93 KDM4E (0.65) MEN1KMT2AKDM4ELMNAMPO
Golotimod SCHEMBL727944 0.93 KDM4E (0.65) MEN1KMT2AKDM4ELMNAMPO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1042286-B1 GAMMA-GLUTAMYL AND BETA-ASPARTYL CONTAINING IMMUNOMODULATOR COMPOUNDS AND METHODS THEREWITH CRAGMONT PHARMACEUTICALS LLC (US) 2010-08-25 — — EP claimed
EP-1042286-B1 GAMMA-GLUTAMYL AND BETA-ASPARTYL CONTAINING IMMUNOMODULATOR COMPOUNDS AND METHODS THEREWITH CRAGMONT PHARMACEUTICALS LLC (US) 2010-08-25 — — EP disclosed
EP-1042286-A1 GAMMA-GLUTAMYL AND BETA-ASPARTYL CONTAINING IMMUNOMODULATOR COMPOUNDS AND METHODS THEREWITH Wei, Edward T. (US) 2000-10-11 — — EP disclosed
WO-1999033799-A1 GAMMA-GLUTAMYL AND BETA-ASPARTYL CONTAINING IMMUNOMODULATOR COMPOUNDS AND METHODS THEREWITH WEI EDWARD T (US) 1999-07-08 — — WO disclosed
Send feedback